GlassScriptPhysician profile
Harsha Sharma
NPI 1306246616
$1,117.09
in general payments reported to CMS, 2019-2025
19 companies · $411 in 2025
The $411 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $75.40 · 2021: $60.00 · 2022: $17.17 · 2023: $106 · 2024: $160 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.04 |
| Education | $183.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $437.30 | 2023-2025 | Veozah |
| Gynesonics, INC. | $148.86 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exact Sciences Corporation | $79.32 | 2023-2025 | Cologuard Collection Kit |
| Ethicon US, LLC | $59.40 | 2019-2020 | |
| Therapeuticsmd, INC. | $55.01 | 2019-2020 | |
| Avion Pharmaceuticals | $50.68 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.31 | 2020-2025 | |
| Exeltis, USA INC. | $39.23 | 2021-2024 | Slynd |
| Abbvie INC. | $38.91 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $27.06 | 2024-2025 | Myfembree |
| Hologic Sales and Service, LLC | $19.32 | 2025 | Aptima |
| Evofem Biosciences, INC. | $19.13 | 2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $17.17 | 2022 | |
| Amgen INC. | $14.66 | 2019 | |
| Minerva Surgical, INC | $14.22 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $13.53 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.21 | 2019 | |
| Mayne Pharma Commercial LLC | $13.06 | 2025 | |
| Millicent US INC | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harsha Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.